Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium Zirconium Cyclosilicate”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Large-scale testing (Phase 3)Study completedNCT03303521
What this trial is testing

Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.

Who this might be right for
Hyperkalemia
AstraZeneca 196
Post-approval studies (Phase 4)Study completedNCT05347693
What this trial is testing

Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study

Who this might be right for
HyperkalaemiaChronic Kidney Disease
AstraZeneca 186
Testing effectiveness (Phase 2)Active Not RecruitingNCT04789239
What this trial is testing

OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure

Who this might be right for
Heart FailureHyperkalemia
Michael Fu 110
Large-scale testing (Phase 3)Ended earlyNCT04847232
What this trial is testing

Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

Who this might be right for
Hyperkalemia
AstraZeneca 2,690
Large-scale testing (Phase 3)Ended earlyNCT04727528
What this trial is testing

Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease

Who this might be right for
HyperkalaemiaMetabolic AcidosisChronic Kidney Disease
AstraZeneca 39
Testing effectiveness (Phase 2)Looking for participantsNCT07029503
What this trial is testing

Swedish Cardiac And Renal Failure Study-1

Who this might be right for
HFrEF - Heart Failure With Reduced Ejection FractionChronic Kidney Disease
Karolinska Institutet 40
Large-scale testing (Phase 3)Ended earlyNCT05056727
What this trial is testing

Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia

Who this might be right for
Renal Insufficiency, ChronicHyperkalemia
AstraZeneca 1,112
Not applicableStudy completedNCT04566653
What this trial is testing

Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia

Who this might be right for
Chronic Kidney Disease + Hyperkalaemia +/- Heart Failure
AstraZeneca 147
Post-approval studies (Phase 4)Ended earlyNCT04997161
What this trial is testing

Study of SZC and Enhanced Nutrition Advice Compared to SoC in Dialysis Patients With Hyperkalaemia

Who this might be right for
Hyperkalaemia
AstraZeneca 3
Large-scale testing (Phase 3)Looking for participantsNCT06578533
What this trial is testing

Keeping RAASi Treatment With Optimal Potassium Control

Who this might be right for
Chronic Kidney Diseases
Fundación para la Investigación del Hospital Clínico de Valencia 78
Not applicableStudy completedNCT06635499
What this trial is testing

VITALIZE.Use and Effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the Real-world Setting in Spain

Who this might be right for
Hyperkalaemia
AstraZeneca 232
Large-scale testing (Phase 3)Study completedNCT03172702
What this trial is testing

Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia

Who this might be right for
Hyperkalemia
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT03337477
What this trial is testing

Evaluate a Potassium Normalization Treatment Regimen Including Sodium Zirconium Cyclosilicate (ZS) Among Patients With S-K ≥5.8

Who this might be right for
Hyperkalemia
AstraZeneca 70
Early research (Phase 1)UnknownNCT04727840
What this trial is testing

Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial)

Who this might be right for
Chronic Kidney DiseasesHyperkalemia
Brigham and Women's Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT04983979
What this trial is testing

The ORTIZ Study: Optimising RASi Therapy With SZC

Who this might be right for
CKDDiabetes Mellitus, Type 2Hyperkalemia
Barts & The London NHS Trust 18
Not applicableStudy completedNCT04207203
What this trial is testing

Healthy Diet Rich in Potassium to Chronic Kidney Disease With Sodium Zirconium Cyclosilicate: A Feasibility Study

Who this might be right for
Chronic Kidney Disease stage4Chronic Kidney Disease Stage 5Hyperkalemia
Karolinska Institutet 26
Testing effectiveness (Phase 2)Ended earlyNCT03532009
What this trial is testing

Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy With Sodium Zirconium Cyclosilicate in Heart Failure

Who this might be right for
Heart Failure
AstraZeneca 182
Early research (Phase 1)Study completedNCT03283267
What this trial is testing

A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS)

Who this might be right for
Hyperkalemia
AstraZeneca 22
Large-scale testing (Phase 3)Study completedNCT03127644
What this trial is testing

ZS Ph2/3 Dose-response Study in Japan

Who this might be right for
Hyperkalemia
AstraZeneca 103
Large-scale testing (Phase 3)Study completedNCT05382988
What this trial is testing

Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy

Who this might be right for
Sodium Zirconium CyclosilicateHyperkalemiaHyperparathyroidism, Secondary
Guangdong Provincial People's Hospital 62
Load More Results